Borosil Renewables Submits Q4FY26 Monitoring Agency Reports for Two Preferential Issues Under SEBI Regulation 32
Borosil Renewables submitted Q4FY26 monitoring agency reports under SEBI Regulation 32 on May 12, 2026, for two preferential issues monitored by ICRA Limited and CARE Ratings Limited. ICRA confirmed INR 235.14 Crore in proceeds monitored for the February 2025 issue with no material deviation, while CARE Ratings reported Rs. 78.72 crore utilised for the October 2025 issue and Rs. 292.77 crore of unutilised proceeds deployed across six money market mutual funds. Both agencies flagged insolvency proceedings initiated by European subsidiaries GMB and Geosphere.

*this image is generated using AI for illustrative purposes only.
Borosil Renewables Limited submitted monitoring agency reports for the quarter ended March 31, 2026, to the stock exchanges on May 12, 2026, in compliance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 162A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The reports were prepared by ICRA Limited and CARE Ratings Limited, serving as monitoring agencies for two distinct preferential issues conducted by the company. Both agencies confirmed that the utilisation of issue proceeds remained in line with the objects disclosed in the respective offer documents, with no material deviation reported.
ICRA Report: February 2025 Preferential Issue
ICRA Limited monitored the proceeds from the preferential issue that opened on February 06, 2025, and closed on February 13, 2025. The issue involved equity shares and fully convertible warrants, with an original issue size of INR 700.00 Crore (1,13,20,754 warrants + 18,86,793 equity at ₹530 each). The issue size was subsequently revised to INR 517.66 Crore (78,80,436 warrants + 18,86,793 equity at ₹530 each) following a board resolution passed through circulation on March 05, 2025. The reduction occurred in two stages — first to INR 697.56 Crore due to the ineligibility of two proposed allottees for warrants, and then to INR 517.66 Crore due to undersubscription. As of March 31, 2026, proceeds credited to the equity and warrant account stood at INR 235.14 Crore, which ICRA monitored for Q4FY2026.
The following table summarises the revised cost of objects and progress in utilisation as monitored by ICRA:
| Metric: | Details |
|---|---|
| Original Issue Size: | INR 700.00 Crore |
| Revised Issue Size: | INR 517.66 Crore |
| Net Proceeds Monitored (Q4FY2026): | INR 235.14 Crore |
| Object: | Original Cost (Rs. Crore) | Revised Cost (Rs. Crore) | Amount Utilised at End of Quarter (Rs. Crore) | Unutilised Amount (Rs. Crore) |
|---|---|---|---|---|
| Repayment/Prepayment of loans: | 15.00 | Nil | - | - |
| Satisfaction of SBLC liability (GMB): | 185.00 | 185.00 | 185.00 | Nil |
| Capex – Solar Glass Facility, Bharuch: | 375.00 | 332.66 | 50.14 | 282.52 |
| General Corporate Purpose: | 125.00 | Nil | - | - |
| Total: | 700.00 | 517.66 | 235.14 | 282.52 |
ICRA noted that INR 20.54 Crore utilised during the quarter towards capital expenditure represents a reimbursement of expenses incurred earlier by the company from its internal accruals. The actual unutilised proceeds stood at INR 473 as only part payment had been received against the warrants as on March 31, 2026, with the closing balance of the HSBC Warrant Account at INR 473.
CARE Ratings Report: October 2025 Preferential Issue
CARE Ratings Limited monitored the proceeds from the preferential issue of equity shares with an issue period of October 10, 2025, to October 17, 2025. The original issue size was Rs. 376.02 crore; however, the actual amount raised was Rs. 371.49 crore owing to undersubscription. CARE Ratings confirmed no deviation from the objects of the issue and noted no major deviation from its previous monitoring agency report dated January 28, 2026, for the quarter ended December 31, 2025.
The following table presents the cost of objects and utilisation progress as reported by CARE Ratings:
| Object: | Original Cost (Rs. Crore) | Revised Cost (Rs. Crore) | Amount Utilised at End of Quarter (Rs. Crore) | Unutilised Amount (Rs. Crore) |
|---|---|---|---|---|
| Capex – Solar Glass Facility, Bharuch: | 317.34 | 317.34 | 68.72 | 248.62 |
| General Corporate Purposes: | 58.68 | 54.15 | 10.00 | 44.15 |
| Total: | 376.02 | 371.49 | 78.72 | 292.77 |
The General Corporate Purposes allocation was revised to ₹54.15 crore owing to undersubscription of equity shares offered to certain investors. The shortfall in proceeds for funding the originally envisaged General Corporate Purposes is proposed to be met through internal accruals, with the restructuring of utilisation of issue proceeds approved by the Board through its resolution dated January 08, 2026. CARE Ratings noted that ₹68.72 crore was spent towards capital expenditure and ₹10.00 crore towards issue-related expenses, tracked through the company's Cash Credit account and sample invoices.
Deployment of Unutilised Proceeds
CARE Ratings reported that the unutilised proceeds of Rs. 292.77 crore were deployed across six money market mutual funds as at March 31, 2026. The company redeemed earlier mutual fund investments and reinvested in Nippon India Money Market Fund and Tata Money Market Fund during Q4FY26.
| Fund: | Amount Invested (Rs. Crore) | Earnings (Rs. Crore) | Market Value at March 31, 2026 (Rs. Crore) |
|---|---|---|---|
| Kotak Money Market Fund: | 58.02 | 1.45 | 59.47 |
| Aditya Birla Sun Life Money Manager Fund: | 57.80 | 1.40 | 59.20 |
| HDFC Money Market Fund: | 57.90 | 1.45 | 59.35 |
| ICICI Prudential Money Market Fund: | 58.42 | 1.45 | 59.87 |
| Nippon India Money Market Fund: | 29.33 | 0.74 | 30.06 |
| Tata Money Market Fund: | 31.30 | 0.77 | 32.07 |
| Total: | 292.77 | 7.25 | 300.02 |
Key Disclosures: Subsidiary Insolvency Proceedings
Both monitoring agencies flagged material developments relating to the company's European subsidiaries. ICRA took note of the exchange disclosure dated July 5, 2025, pertaining to GMB Glasmanufaktur Brandenburg GmbH (GMB), a step-down subsidiary, whose Managing Director filed an insolvency application on July 4, 2025, before the insolvency court at Cottbus, Germany, citing the absence of clear indications of demand recovery and possible liquidity issues. ICRA noted that INR 185 Crore of issue proceeds had been utilised towards satisfaction of financial liabilities of GMB during Q4FY2025.
CARE Ratings additionally noted the exchange disclosure dated December 23, 2025, pertaining to Geosphere Glassworks GmbH (Geosphere), the wholly owned subsidiary that held a majority stake in GMB. Geosphere filed for insolvency on December 22, 2025, after a German Government Bank claimed recovery of a capital subsidy of EUR 4.81 million granted to GMB, alleging non-compliance with subsidy conditions following GMB's insolvency. CARE Ratings noted that with the initiation of insolvency proceedings, the Group has lost control over both GMB and Geosphere. The reports were submitted to the stock exchanges by Company Secretary and Compliance Officer Kishor Talreja (Membership No. FCS – 7064).
Historical Stock Returns for Borosil Renewables
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.79% | -4.49% | +11.30% | -19.63% | -0.16% | +88.38% |
How will the insolvency of both GMB and Geosphere impact Borosil Renewables' consolidated financials and its ability to deploy the remaining INR 282.52 crore earmarked for the Bharuch solar glass facility?
With over INR 575 crore in combined unutilised proceeds still pending deployment across both preferential issues, what is the revised timeline for completing the solar glass facility capex at Bharuch?
Given the undersubscription in both the February 2025 and October 2025 preferential issues, does Borosil Renewables plan to raise additional capital to bridge the funding gap for its expansion plans?


































